logo
NNI, Lien Foundation roll out early palliative care for patients with neurological conditions

NNI, Lien Foundation roll out early palliative care for patients with neurological conditions

Straits Times4 days ago

Palliative care patient Chia Shyh Shen (bottom) practising on a communication device with Tan Tock Seng Hospital staff on May 29. ST PHOTO: KUA CHEE SIONG
SINGAPORE – The first time Mr Chia Shyh Shen experienced weakness in his right arm, he thought little of it.
It was 2021, and the now-71-year-old was trying to change a ceiling light bulb at home.
He could not hold his arm raised. At the time , he and his wife, Madam Tam Fee Chin, 70, attributed what they thought was temporary weakness to old age.
But soon, M r Chia, who along with his wife was employed at a relative's gold jewellery shop in Johor Bahru, could not even lift a tray at work.
Mr Chia was diagnosed in October 2021 with amyotrophic lateral sclerosis (ALS), t he most common type of motor neurone disease, which affects how nerve cells communicate with the muscles .
In 2022, the Malaysian couple sought help in Singapore.
There is no cure for ALS, which was formerly known as Lou Gehrig's disease. There are around 300 to 400 people living with ALS in Singapore.
The condition is more common to individuals older than 50, and afflicts more men than women.
Mr Chia is becoming weaker as his motor neurons – the nerve cells sending signals from the brain and spinal cord to the muscles, enabling movement – degenerate and die. He now has minimal mobility below the neck.
And as his disease progresses, he will lose the ability to speak, eat and , finally, breathe.
Mr Chia, however, remains cheerful, and is looking forward to future trips.
His doctor at the National Neuroscience Institute@Tan Tock Seng Hospital, where Mr Chia is a patient, is helping to make sure this stays the case for as long as possible.
While this may not sound like much , it reflects the transformation of care that is taking place there, particularly after NNI and the Lien Foundation rolled out in April 2024 a $6.8m five-year initiative to provide palliative care from diagnosis onwards.
They call it NeuroPal, which stands for Neuropalliative Ecosystem of care.
Prior to 2024, patients were referred to palliative care after experiencing advanced symptoms, said Dr Ang Kexin, a senior consultant at NNI, who has undergone training in palliative care.
'They came to me when they were bed bound or could not talk. Now they come earlier and can express their needs,' she said. 'We ask them about their hobbies... We anticipate their needs. We journey with them.'
NNI and the Lien Foundation held a press conference on May 29 to announce NeuroPal and its aim of integrating palliative care into standard neurological care.
It will go some way to help alleviate the suffering of patients living with ALS , dementia, Parkinson's disease and other complex brain, spine, nerve and muscle conditions.
Palliative care patient Chia Shyh Shen (bottom) was diagnosed in October 2021 with amyotrophic lateral sclerosis, the most common type of motor neurone disease, which affects how nerve cells communicate with the muscles.
ST PHOTO: KUA CHEE SIONG
NeuroPal has screened nearly 2000 NNI patients with neurological conditions, of which 370 patients are given palliative care.
NNI@SGH started the programme at one clinic in 2024. By the time NeuroPal ends in five years' time , it should have supported more than 3,600 NNI patients annually at TTSH and SGH, said NNI and the Lien Foundation.
The hope is to expand it to other hospitals, and more community care partners. NNI specialists treat patients at seven hospitals across Singapore.
With NeuroPal, patients are routinely screened for psychosocial issues and support can then be tailored for them, based on their distress levels.
Associate Professor Adeline Ng, Senior Consultant, Neurology, NNI and NeuroPal co-lead, said they use a self-reported short questionnaire called the Distress Thermometer to understand what matters most to the patients.
The initiative pumps funding into training and hiring more palliative care staff, including two psychologists, three medical social workers, four nurses and others.
Palliative care patient Chia Shyh Shen (bottom) with Tan Tock Seng hospital staff (from centre-left) National Neuroscience Institute Senior Consultant Dr Ang Kexin, Principal Occupational Therapist Huang Huixin and Senior Speech Therapist Yong Xing Tong at the Centre for Geriatric Medicine, in Tan Tock Seng Hospital, on May 29.
ST PHOTO: KUA CHEE SIONG
Lien Foundation's CEO Lee Poh Wah said during the press conference that with the initiative, they want to dismantle the misconception that palliative care is only for the end of life.
'It's naive to frame neurological diseases as a battle to be fought at all costs... I think we need a more humane and humble approach to healthcare, one that acknowledges the complexities of living with serious illness.'
Palliative care aims to help relieve the symptoms and stress of serious illness and support caregivers, and it can help to reduce unnecessary suffering when it is given early in the disease trajectory, he said.
Neurological conditions often unfold as a long journey of progressive decline, where a patient suffers emotional distress and is gradually robbed of his or her independence.
Among those who receive palliative care, 60 per cent are cancer patients, but cancer only accounts for 26 per cent of all deaths, he said.
The hope is to train more healthcare professionals to deliver general palliative care, he added.
Associate Professor David Low, Deputy CEO (Clinical), NNI, told the media that people often think of palliative care as something that is given at the terminal stages of life.
But for neurological conditions, the care can start early, for instance, when a person is diagnosed with motor neuron disease.
ALS patients typically live for around 3 to 5 years, but there are a lot of outliers, and Mr Chia is one of them, said Dr Ang.
To help improve his quality of life, the NeuroPal team at NNI@TTSH regularly monitor him and recommend solutions to help him cope with the inevitable changes that the disease brings.
They recently let him try out an eye-tracking device called Tobii, which will enable him to communicate with others or pick out videos to watch, and a tilted wheelchair that can support his neck.
'We are future-proofing him. With Tobii, he can learn it faster now because he can still communicate verbally,' Dr Ang said.
With that wheelchair, should he opt to buy it, he can travel in greater comfort, she added.
Join ST's WhatsApp Channel and get the latest news and must-reads.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial
S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial

Straits Times

time8 hours ago

  • Straits Times

S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial

Researchers involved in the project include (from left) Professor Lim Kah Leong, President's Chair in Translational Neuroscience at the Lee Kong Chian School of Medicine; Associate Professor Prakash Kumar, head and senior consultant at the department of neurology at the National Neuroscience Institute (NNI); Professor Louis Tan, NNI's director of research; and Professor Tan Eng King, NNI's deputy chief executive officer for academic affairs. ST PHOTO: NG SOR LUAN S'pore researchers to study stem cell transplants in brain for Parkinson's disease in novel trial SINGAPORE - Researchers from the National Neuroscience Institute (NNI) are embarking on a ground-breaking project to transplant stem cells into the brains of those with early Parkinson's disease, in a bid to stop the disease in its tracks. Planning for the first-of-its-kind trial in Singapore is still under way, pending regulatory and ethical approvals. Researchers are hopeful that the phase one trial for the novel approach can begin in late 2026, with five to eight patients who are younger and facing complications with their current treatments. The project is being funded under a $25 million research grant awarded on May 28 to the institute by the National Medical Research Council for five years to study Parkinson's disease. The programme is called Singapore Parkinson's Disease Programme, or Sparkle. An estimated 8,000 people in Singapore live with Parkinson's disease, which happens when dopamine-producing cells in the brain progressively die. As dopamine levels fall, patients present symptoms such as tremors and stiffness, and slowed movement appears. There is no known cure for the neurodegenerative disease, which leads to difficulty with walking, balance, coordination and even speech. The idea of replacing brain cells killed off by Parkinson's with stem cells has been around for about four decades. The hope is that the transplanted cells, which have the ability to evolve into different types of specialised cells, can then start producing dopamine, reversing the condition. But progress was held back by ethical considerations and technical hurdles. Professor Tan Eng King, principal investigator for Sparkle and NNI's deputy chief executive officer for academic affairs, said that in the past, stem cells from embryos and foetuses were used, raising ethical concerns . There were also mixed results, as some transplanted cells did not end up producing dopamine, and led to adverse side effects like involuntary limb movements. With advancements in cell therapies in recent years, scientists are now able to convert a patient's own normal body cells, such as skin or blood cells, into stem cells. Using a patient's own cells is a better approach as it reduces the risk of the body's immune system rejecting the transplanted cells. Prof Tan said NNI has collaborated with Duke-NUS Medical School, Lee Kong Chian School of Medicine and A*Star to develop a proprietary method of converting a person's normal cells into stem cells. The therapy is currently undergoing final approval by the US Food and Drug Administration before it can be used for the trial. He added that researchers from other countries are also studying similar stem cell approaches for Parkinson's disease. The most successful group will be the one 'that is able to create a stem cell source from using a patient's own cells that contains almost 100 per cent dopamine-producing cells and nothing else', said Prof Tan. 'This is a very challenging endeavour and it is not something that anybody can do. We have developed the expertise, and we think that potentially, we can be one of the pioneers,' he added. After the stem cells are transplanted, patients on the trial will likely be monitored for about two years to evaluate the safety and effectiveness of the approach. Other than the stem cell trial, another initiative under Sparkle is an early screening programme in the community to identify those at high risk of developing Parkinson's disease. Prof Tan said he is optimistic that the screening programme can be rolled out by the end of 2025, and reach 10,000 people over the age of 55 in the next three to five years. Currently, in Singapore, there is no screening available to detect those at risk of developing Parkinson's disease. But Prof Tan said that based on previous research done by NNI, those who suffer from a loss of sense of smell, have rapid eye movement sleep disorder (where people act out their dreams) and a particular gene variant have a higher chance of developing the disease. The screening will involve a questionnaire, after which those whose results warrant a closer look will be invited to go for more detailed examinations like brain scans. Those who are identified as having a high risk of developing the disease will be introduced to interventions, including making lifestyle changes in areas such as exercise and diet. Prof Tan pointed out that Singapore has one of the highest life expectancies in the world. 'If you can reduce the risk of developing a neurodegenerative condition, then you can increase the amount of years that you can spend in healthier living,' he said. Join ST's WhatsApp Channel and get the latest news and must-reads.

Brunei ruler discharged from hospital, resting in Malaysia
Brunei ruler discharged from hospital, resting in Malaysia

Business Times

timea day ago

  • Business Times

Brunei ruler discharged from hospital, resting in Malaysia

[KUALA LUMPUR] Brunei's ruler, Sultan Hassanal Bolkiah, has been discharged from a Malaysian hospital and will rest for several days in Malaysia, the Brunei Prime Minister's Office said late on Saturday (May 31). The sultan, 78, has returned to the Grand Hyatt Hotel to rest following advice from medical experts before returning to Brunei, it said in a statement. He was admitted to the National Heart Institute for fatigue during a meeting of South-east Asian leaders last week in Kuala Lumpur. It is not known when the ruler will return to Brunei. The queen and other members of the royal family were with him, the statement said. The sultan holds multiple roles in the small South-east Asian nation, serving as Brunei's prime minister, armed forces commander, finance minister, foreign minister and defence minister. REUTERS

Brunei Sultan discharged from KL hospital
Brunei Sultan discharged from KL hospital

Straits Times

time2 days ago

  • Straits Times

Brunei Sultan discharged from KL hospital

Brunei's Sultan Hassanal Bolkiah (centre) was admitted to hospital in Kuala Lumpur on May 27 due to fatigue. PHOTO: AFP KUALA LUMPUR - Brunei's Sultan Hassanal Bolkiah has been discharged from hospital and will remain in the Malaysian capital for a few more days to rest, his office said on May 31. Sultan Hassanal was admitted to hospital in Kuala Lumpur on May 27 due to fatigue, though his office had insisted the world's longest-serving monarch was in 'good health'. 'His Majesty Sultan Hassanal Bolkiah ... praise be to God, is back at the Grand Hyatt Hotel after resting a few days at the National Heart Institute, Kuala Lumpur,' his office said in an Instagram post on May 31. 'Medical experts have advised His Majesty to continue resting for a few more days before departing back to Brunei,' it added. The 78-year-old sultan was in Kuala Lumpur for a summit with other Association of Southeast Asian Nations leaders. A statement from the Brunei Prime Minister's Office – a position held by the sultan – on May 27 said the monarch had been feeling tired and that Malaysian health experts had advised him to rest for a few days at the National Heart Institute. Sultan Hassanal ascended the throne in 1967. He is one of the richest people in the world, and comes from a family that has ruled Brunei, a small Muslim nation perched on the north of the tropical island of Borneo, for more than 600 years. His decades ruling Brunei have seen the country gain full independence from Britain and living standards soar to among the highest globally. But his reign has also been marked by controversies including the introduction of tough Islamic laws legislating penalties such as severing of limbs and death by stoning. AFP Join ST's Telegram channel and get the latest breaking news delivered to you.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store